---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-005496"
form_type: "8-K"
ticker: "SBFM"
cik: "0001402328"
company_name: "Sunshine Biopharma Inc."
filed_at: "2024-08-12T23:59:59+00:00"
generated_at: "2026-05-31T09:59:38.902543+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Sunshine Biopharma announces 1-for-20 reverse stock split, effective Aug 8

## Summary
- 1-for-20 reverse stock split effective August 8, 2024; each share converted to one-twentieth of a share.
- Certificate of amendment filed with Colorado Secretary of State on August 7, 2024.
- Reverse split applies to all outstanding shares of common stock; no change in authorized shares or par value.

## SEC filing metadata
- accession: 0001683168-24-005496
- form_type: 8-K
- ticker: SBFM
- cik: 0001402328
- company_name: Sunshine Biopharma Inc.
- filed_at: 2024-08-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1402328/000168316824005496/0001683168-24-005496-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1402328/000168316824005496/sunshine_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-005496
- JSON: https://secwatch.observer/filing/0001683168-24-005496.json
- Plain text: https://secwatch.observer/filing/0001683168-24-005496.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.